Sarcoidosis of other sites
ICD-10 D86.89 is a billable code used to indicate a diagnosis of sarcoidosis of other sites.
Sarcoidosis is a systemic granulomatous disease characterized by the formation of non-caseating granulomas in various organs. While the lungs are the most commonly affected site, sarcoidosis can also involve other organs such as the skin, eyes, liver, spleen, and lymph nodes. The etiology of sarcoidosis remains unclear, but it is believed to involve an abnormal immune response to environmental triggers in genetically predisposed individuals. Patients may present with a variety of symptoms depending on the organs involved, including respiratory symptoms, skin lesions, and systemic manifestations such as fatigue and fever. In cases where sarcoidosis affects sites other than the lungs, it can lead to complications such as hypercalcemia, pulmonary hypertension, and organ dysfunction. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and histological confirmation through biopsy. The management of sarcoidosis may include observation, corticosteroids, and immunosuppressive therapy, depending on the severity and extent of the disease.
Detailed pulmonary function tests and imaging studies.
Patients presenting with respiratory symptoms and abnormal chest X-rays.
Ensure clear documentation of lung involvement versus other organ systems.
Comprehensive assessment of systemic symptoms and organ involvement.
Patients with joint pain and systemic symptoms suggestive of sarcoidosis.
Document any autoimmune conditions that may coexist.
Used for diagnostic purposes in patients with pleural effusion suspected to be due to sarcoidosis.
Document indication for procedure and findings.
Pulmonologists should ensure clear documentation of the need for thoracentesis.
Common symptoms include fatigue, shortness of breath, skin lesions, swollen lymph nodes, and joint pain. Symptoms can vary widely depending on the organs involved.
Diagnosis typically involves a combination of clinical evaluation, imaging studies (like chest X-rays or CT scans), and biopsy of affected tissues to confirm the presence of non-caseating granulomas.
